Back
Norwegian Cruise Line Holdings Vs. Novo Nordisk AS Industry Stock Comparison
Buy
77
NCLH
Norwegian Cruise Line Holdings
Last Price:
$26.37
Seasonality Move:
-3.7%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.33
Seasonality Move:
6.58%
Buy
77
Norwegian Cruise Line Holdings (NCLH)
is a Buy
Is Norwegian Cruise Line Holdings a Buy, Sell or Hold?
-
The current Norwegian Cruise Line Holdings [NCLH] share price is $26.13. The Score for NCLH is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
NCLH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NCLH Stock Price Chart
What is Norwegian Cruise Line Holdings's stock price today?
-
The Norwegian Cruise Line Holdings share price today is $26.13The current trend is relatively stagnant and NCLH is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NCLH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.49 | Sell |
| Chaikin Money Flow: | -1147010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.03 - 27.49) | Sell |
| Bollinger Bands (100): | (17.85 - 26.37) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.52 | Sell |
| Relative Strength Index (14 RSI): | 27.28 | Sell |
| Chaikin Money Flow: | 14079249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.16 - 111.42) | Sell |
| Bollinger Bands (100): | (106.53 - 131.27) | Sell |
NCLH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.27 | Sell |
| 20-day SMA: | 26.84 | Sell |
| 50-day SMA: | 25.94 | Buy |
| 200-day SMA: | 20.17 | Buy |
| 8-day EMA: | 26.3 | Sell |
| 20-day EMA: | 26.49 | Sell |
| 50-day EMA: | 25.41 | Buy |
| 200-day EMA: | 21.21 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.84 | Sell |
| 20-day SMA: | 105.84 | Sell |
| 50-day SMA: | 108.65 | Sell |
| 200-day SMA: | 126.03 | Sell |
| 8-day EMA: | 99.1 | Sell |
| 20-day EMA: | 103.93 | Sell |
| 50-day EMA: | 109.19 | Sell |
| 200-day EMA: | 117.8 | Sell |
Norwegian Cruise Line Holdings Earnings Growth & NCLH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $0.44 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
Norwegian Cruise Line Holdings Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||